Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yvonne Ladiges"'
Autor:
Christine Y.L. Tham, Janine Kah, Anthony T. Tan, Tassilo Volz, Adeline Chia, Katja Giersch, Yvonne Ladiges, Alessandro Loglio, Marta Borghi, Camille Sureau, Pietro Lampertico, Marc Lütgehetmann, Maura Dandri, Antonio Bertoletti
Publikováno v:
Cell Reports Medicine, Vol 1, Iss 4, Pp 100060- (2020)
Summary: Hepatitis delta virus (HDV) requires hepatitis B virus (HBV) to complete its infection cycle and causes severe hepatitis, with limited therapeutic options. To determine the prospect of T cell therapy in HBV/HDV co-infection, we study the imp
Externí odkaz:
https://doaj.org/article/6d4ddfe9419f438f9c91e9142a2b1cb6
Autor:
Lena Allweiss, Yvonne Ladiges, Maura Dandri, Tassilo Volz, Ansgar W. Lohse, A Pirosu, Katja Giersch, Marc Lütgehetmann, JH Bockmann
Publikováno v:
37. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::440d0f2109072a724864006a3e5270ee
https://doi.org/10.1055/s-0040-1722084
https://doi.org/10.1055/s-0040-1722084
Autor:
Anthony T. Tan, Tassilo Volz, Maura Dandri, J Kah, Marta Borghi, Yvonne Ladiges, Antonio Bertoletti, Marc Lütgehetmann, Pietro Lampertico, Adeline Chia, Camille Sureau, Christine Y.L. Tham, Alessandro Loglio, Katja Giersch
Publikováno v:
Cell Reports Medicine, Vol 1, Iss 4, Pp 100060-(2020)
Cell Reports Medicine
Cell Reports Medicine
Summary Hepatitis delta virus (HDV) requires hepatitis B virus (HBV) to complete its infection cycle and causes severe hepatitis, with limited therapeutic options. To determine the prospect of T cell therapy in HBV/HDV co-infection, we study the impa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a33bced8547233b91fc2051e2c7cf4e
http://www.sciencedirect.com/science/article/pii/S2666379120300768
http://www.sciencedirect.com/science/article/pii/S2666379120300768
Autor:
Martin Trippler, Yvonne Ladiges, Ruth Broering, Guido Gerken, Heiner Wedemeyer, Maura Dandri, Xufeng Luo, Zhenhua Zhang, CI Real, Joerg F. Schlaak, Juergen Treckmann, M Werner, Olympia E. Anastasiou, Andreas Paul, Hideo A. Baba, Stefan Schefczyk, Thekla Kemper, Lena Allweiss, Mengji Lu
Background and aims To date, conflicting data exist as to whether hepatitis B virus (HBV) has the ability to induce innate immune responses. Here, we investigated cellular changes after the first contact between HBV and primary human hepatocytes (PHH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f72c13e1eaa73ddcc5ab887212bb1131
https://www.ncbi.nlm.nih.gov/pubmed/31925967
https://www.ncbi.nlm.nih.gov/pubmed/31925967
Autor:
Marta Borghi, Maura Dandri, Pietro Lampertico, Anthony T. Tan, J Kah, Yvonne Ladiges, Christine Y.L. Tham, Camille Sureau, Marc Lütgehetmann, Alessandro Loglio, Antonio Bertoletti, Adeline Chia, Katja Giersch, Tassilo Volz
Publikováno v:
SSRN Electronic Journal.
Hepatitis Delta virus (HDV) requires hepatitis B virus (HBV) to complete its infection cycle and causes a severe hepatitis with limited therapeutic options. To determine the prospect of T cell therapy in HBV/HDV co-infection, we first studied the HDV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05efae7a5d010e5b9e35664f875b3634
https://doi.org/10.2139/ssrn.3545998
https://doi.org/10.2139/ssrn.3545998